tiprankstipranks
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market

Neuphoria Therapeutics (NEUP) Technical Analysis

Compare
238 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
4Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Neuphoria Therapeutics’s (NEUP) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting Neuphoria Therapeutics is a Sell.
Neuphoria Therapeutics’s (NEUP) 20-Day exponential moving average is 5.12, while Neuphoria Therapeutics’s (NEUP) share price is $5.52, making it a Buy.
Neuphoria Therapeutics’s (NEUP) 50-Day exponential moving average is 4.82, while Neuphoria Therapeutics’s (NEUP) share price is $5.52, making it a Buy.

Neuphoria Therapeutics (NEUP) Pivot Points

Mar 27, 2025, 08:08 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.85
5.08
5.24
5.47
5.63
5.86
6.02
Fibonacci
5.08
5.23
5.32
5.47
5.62
5.71
5.86
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neuphoria Therapeutics (NEUP) Moving Averages

Mar 27, 2025, 08:08 AM
Period
Simple
Exponential
MA5
5.31Buy
5.33Buy
MA10
5.10Buy
5.22Buy
MA20
5.14Buy
5.12Buy
MA50
4.75Buy
4.82Buy
MA100
4.15Buy
4.87Buy
MA200
5.67Sell
6.37Sell
Neuphoria Therapeutics’s (NEUP) 10-Day exponential moving average is 5.22, while Neuphoria Therapeutics’s (NEUP) share price is $5.52, making it a Buy.
Neuphoria Therapeutics’s (NEUP) 100-Day exponential moving average is 4.87, while Neuphoria Therapeutics’s (NEUP) share price is $5.52, making it a Buy.
Neuphoria Therapeutics’s (NEUP) stock price is $5.52 and Neuphoria Therapeutics’s (NEUP) 50-day simple moving average is 4.75, creating a Buy signal.
Neuphoria Therapeutics’s (NEUP) stock price is $5.52 and Neuphoria Therapeutics’s (NEUP) 100-day simple moving average is 4.15, creating a Buy signal.
Neuphoria Therapeutics’s (NEUP) stock price is $5.52 and Neuphoria Therapeutics’s (NEUP) 200-day simple moving average is 5.67, creating a Sell signal.

Neuphoria Therapeutics (NEUP) Technical Indicators

Mar 27, 2025, 08:08 AM
Name
Value
Implied Action
RSI (14)
61.87
Neutral
STOCH (9,6)
82.75
Sell
STOCHRSI (14)
76.89
Neutral
MACD (12,26)
0.14
Sell
ADX (14)
39.59
Neutral
Williams %R
-17.07
Sell
CCI (14)
129.32
Sell
ATR (14)
0.50
-
Ultimate Oscillator
58.48
Neutral
ROC
6.36
Buy
Neuphoria Therapeutics’s (NEUP) Relative Strength Index (RSI) is 61.87, creating a Neutral signal.
Neuphoria Therapeutics’s (NEUP) Trend Strength Indicator (ADX) is 39.59, creating a Neutral signal.
Neuphoria Therapeutics’s (NEUP) Commodity Channel Index (CCI) is 129.32, creating a Sell signal.
Neuphoria Therapeutics’s (NEUP) Price Rate of Change (ROC) is 6.36, creating a Buy signal.

FAQ

Is NEUP a Buy, Hold, or Sell?
Based on NEUP’s technical indicators, NEUP is a Buy.
    What is NEUP’s RSI (14)?
    NEUP’s RSI (14) is 61.87, which suggests NEUP is a Neutral.
      What is NEUP’s MACD?
      NEUP’s MACD is 0.14, which suggests NEUP is a Sell.
        What is NEUP’s 5-day moving average?
        NEUP’s 5-day moving average is 5.31, which suggests NEUP is a Buy.
          What is NEUP’s 20-day moving average?
          NEUP 20-day moving average is 5.14, which suggests NEUP is a Buy.
            What is NEUP’s 50-day moving average?
            NEUP’s 50-day moving average is 4.75, which suggests NEUP is a Buy.
              What is NEUP’s 200-day moving average?
              NEUP’s 200-day moving average is 5.67, which suggests NEUP is a Sell.
                What is NEUP’s Williams % R (14)?
                NEUP’s Williams % R (14) is -17.07, which suggests NEUP is a Sell.
                  What is NEUP’s CCI (14)?
                  NEUP’s CCI (14) is 129.32, which suggests NEUP is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis